№ files_lp_4_process_3_057954
File format: docx
Character count: 14640
File size: 257 KB
Systematic case series of coroners’ reports detailing thromboembolism-related deaths, including frequency, distribution, and classification of Prevention of Future Death reports across England and Wales.
Year:
2013–2022
Region / Country:
England and Wales
Topic:
Thromboembolism-related deaths
Document Type:
Supplementary Appendix to systematic case series
Institution:
Judiciary of England and Wales
Author:
Not specified
Data Source:
NHS England Digital, Office for National Statistics
Target Audience:
Healthcare professionals, coroners, researchers
Geographic Scope:
National
Time Period Covered:
2013–2022
Data Categories:
Yearly PFD counts, thromboembolism-related PFDs, thromboembolism deaths, location of events, coroner area, administrative regions, Judiciary categories
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / city:
Australia
Theme:
Hepatitis B, Vaccination, Disease Surveillance
Document type:
Epidemiological review
Organ / institution:
Australian Government Department of Health
Authors:
Nicole Sonneveld, Joanne Jackson, Aditi Dey, Stephen Lambert, Katrina Clark, Benjamin Cowie, Kristine Macartney, Frank Beard
Target audience:
Researchers, health professionals, policymakers
Period of action:
2000–2019
Approval date:
24/06/2024
Date of changes:
N/A
Year:
2014
Region:
Texas, USA
Program:
Medicaid and CHIP
Document Type:
Technical Notes / Report
Organization:
Institute for Child Health Policy, University of Florida
External Reviewer:
External Quality Review Organization for Texas Medicaid Managed Care and CHIP
Author:
Not specified
Target Audience:
Healthcare providers, hospital administrators, policymakers
Issue Date:
March 21, 2016
Content:
Methodology, data inclusion criteria, POA quality checks, PPC calculations, hospital and state-level PPC results
Measurement Year:
Calendar Year 2014
PPC Categories:
65
POA Quality Check Levels:
Red zone, Grey zone
Excluded Populations:
Dual-eligible Medicaid/Medicare, low-volume hospitals, severe or catastrophic illness patients
Year:
2013–2022
Region:
Europe
Countries:
Austria; Belgium; Denmark; Finland; France; Germany; Iceland; Ireland; Italy; Luxembourg; Netherlands; Norway; Spain; Sweden; Switzerland; United Kingdom; Albania; Andorra; Belarus; Bosnia and Herzegovina; Bulgaria; Croatia; Cyprus; Guernsey; Hungary; Jersey; Kosovo; Liechtenstein; Moldova; Montenegro; Serbia; Ukraine
Thematic Area:
Entrepreneurship, Economic Growth, Financial Development, Institutional Factors
Type of Document:
Academic Research Methodology Section
Data Type:
Panel Data
Population:
European countries classified as developed and developing
Classification Framework:
Factor-driven, Efficiency-driven, Innovation-driven economies according to Global Competitiveness Report
Dependent Variable:
New Entrepreneur Entry Rate (NER)
Independent Variables:
Financial Development (FD1, FD2); Corruption Control (CC); Trust (TR); Number of Business Startup Procedures (PRO); Access to Credit (AC)
Control Variables:
GDP (PPP, base year 2010); GDP growth; Population Size; Population Growth; Dummy Year Variables
Data Sources:
World Bank; Worldwide Governance Indicators; World Value Survey; WBEGS
Methodology:
Descriptive design with regression models and interaction terms
Time Frame of Analysis:
2013–2022
Year:
2023
Volume:
47
Publication date:
26/06/2023
Journal:
Communicable Diseases Intelligence
DOI:
10.33321/cdi.2023.47.36
Region:
Wide Bay, Queensland, Australia
Country:
Australia
Subject:
Epidemiology of Q fever
Keywords:
Q fever; zoonoses; rural health; vaccination; urbanisation
Type of document:
Peer-reviewed journal article
Data source:
Queensland Health Notifiable Conditions System (NoCS)
Study period:
2013–2022
Comparison periods:
2013–2017 and 2018–2022
Number of cases:
87
Ethics approval:
Central Queensland HHS Human Research Ethics Committee (exemption granted)
Authors:
Matthew Roughan; Emma Hodge; Arifuzzaman Khan; Josette Chor
Institutional affiliation:
Wide Bay Public Health Unit; Queensland Health
Methodology:
Retrospective analysis of notified cases with statistical comparison of incidence rates, demographics and exposure history
Population classification model:
Modified Monash Model
Public health focus:
Notification trends, exposure patterns, vaccination considerations
Year:
2013–2022
Country:
United States
Issuing Body:
U.S. Citizenship and Immigration Services
Issuing Division:
USCIS Refugee, Asylum and International Operations Directorate
Related Program:
Afghan Operation Allies Welcome (OAW)
Legal References:
8 CFR 208.4(a)(5)(iv)
Subject:
Asylum one-year filing deadline and extraordinary circumstances exceptions
Population Concerned:
Afghan nationals, parolees, and Temporary Protected Status beneficiaries
Document Types:
Frequently Asked Questions; Asylum Officer Training Course excerpt; Temporary Protected Status designation notice; Attorney’s note
Dates of Publication:
May 6, 2013; May 20, 2022; June 30, 2022
Year:
2013–2022
Region / City:
Nigeria
Subject:
Corporate Governance and Tax Planning
Document Type:
Research Article
Institution / Organization:
Not specified
Author:
Not specified
Target Audience:
Academics, regulators, corporate boards, policy makers
Methodology:
Ex-post facto study using secondary panel data
Data Scope:
Fifty-four publicly traded companies across ten sectors
Analysis Techniques:
Descriptive statistics, correlation analysis, panel regression (GLS Random Effects)
Key Concepts:
Risk committee size, accounting expertise, independence, effective tax rate, tax aggressiveness
Year:
[year]
Region / City:
[region]
Topic:
Anticoagulation, Venous Thromboembolism, Kidney Disease
Document Type:
Clinical Practice Guideline
Institution / Organization:
UK Kidney Association
Author:
Kathrine Parker, Albert Power, Yvonne Bernes, Kate Bramham, Richard Buka, Satarupa Choudhuri, Mark Davies, Maria A Gauci, Lauren Hall, Alan Hancock, John Hartemink, Ed Jenkinson, Nicola Korn, Donna Lewis, Gregory Y.H. Lip, Katy Mills, Anneka Mitchell, Lara Roberts, Huw Rowswell, Hannah Stacey, Katherine Stirling, Jecko Thachil, Jung Tsang, Isaac Tseng
Target Audience:
Healthcare professionals in nephrology, haematology, and related fields
Period of Application:
Ongoing
Approval Date:
[month] [year]
Amendment Date:
[month] [year]
Document type:
Clinical guideline appendix
Chapter:
8 Plastic Surgery
Appendix:
1
Subject:
Perioperative venous thromboembolism prophylaxis
Content:
Summary of the quality of studies
Focus:
Deep vein thrombosis (DVT) and pulmonary embolism (PE)
Population:
Patients undergoing plastic and reconstructive surgery
Interventions:
Chemoprophylaxis, mechanical prophylaxis, risk assessment models, anticoagulation strategies
Outcomes:
DVT incidence, VTE incidence, bleeding rate, free flap failure rate, mortality
Risk of bias assessment:
Low, Intermediate, High
Studies included:
Observational studies and comparative studies
Update status:
First update
Department:
Heamatology/Orthopaedic/Pharmacy
Target audience:
Parents and carers of hospitalised children aged 13 and above
Risks:
Deep Vein Thrombosis, Pulmonary Embolism, Cerebral Venous Sinus Thrombosis
Preventive measures:
Mobility, hydration, physiotherapy, risk assessment, medication, compression stockings
Medication:
Enoxaparin (Clexane®), subcutaneous injection, anticoagulant
Instructions:
Dosage, administration guidance, sharps disposal
Emergency signs:
Swelling, pain, breathlessness, chest pain, severe headache, fits, vomiting, weakness
Setting:
Hospital, Alder Hey Children’s NHS Foundation Trust
Region:
United Kingdom
Type of document:
Patient information leaflet
Year:
2026
Region / city:
Belgrade, Serbia; London, UK
Topic:
Atrial fibrillation, Renal failure, Thromboembolism, Bleeding management
Document type:
Academic article
Author:
Tatjana Potpara, A. John Camm
Target audience:
Healthcare professionals, Researchers
Period of validity:
N/A
Date of approval:
N/A
Date of amendments:
N/A
Context:
This academic article discusses the management of thromboembolic and bleeding risks in end-stage renal disease patients with atrial fibrillation, comparing anticoagulants and left atrial appendage closure.
Year:
2026
Region / City:
International cohorts (UK, USA, Germany, Sweden, Japan, Italy, Netherlands, Canada, Finland, Spain, Australia)
Topic:
Cardiovascular risk factors and venous thromboembolism
Document Type:
Research article
Organization / Institution:
Emerging Risk Factors Collaboration, UK Biobank
Authors:
John Gregson, Stephen Kaptoge, Thomas Bolton, Lisa Pennells, Peter Willeit, Stephen Burgess, Steven Bell, Michael Sweeting, Eric B Rimm, Christopher Kabrhel, Bengt Zöller, Gerd Assmann, Vilmundur Gudnason, Aaron R Folsom, Volker Arndt, Astrid Fletcher, Paul E Norman, Børge G Nordestgaard, Akihiko Kitamura, Bakhtawar K Mahmoodi, Peter H Whincup, Matthew Knuiman, Veikko Salomaa, Christa Meisinger, Wolfgang Koenig, Maryam Kavousi, Henry Völzke, Jackie A Cooper, Toshiharu Ninomiya, Edoardo Casiglia, Beatriz Rodriguez, Yoav Ben-Shlomo, Jean-Pierre Després, Leon Simons, Elizabeth Barrett-Connor, Cecilia Björkelund, Marlene Notdurfter, Daan Kromhout, Jackie Price, Susan E Sutherland, Johan Sundström, Jussi Kauhanen, John Gallacher, Joline WJ Beulens, Rachel Dankner, Cyrus Cooper, Simona Giampaoli, Jason F Deen, Agustín Gómez de la Cámara, Lewis H Kuller, Annika Rosengren, Peter J Svensson, Dorothea Nagel, Carlos J. Crespo, Hermann Brenner, Juan R. Albertorio-Diaz, Robert Atkins, Eric J Brunner, Martin Shipley, Inger Njølstad, Deborah A Lawlor, Yvonne T van der Schouw, Randi Marie Selmer, Maurizio Trevisan, W M Monique Verschuren, Philip Greenland, Sylvia Wassertheil-Smoller, Gordon D O Lowe, Angela M Wood, Adam S Butterworth, Simon G Thompson, John Danesh, Emanuele Di Angelantonio, Tom Meade
Target Audience:
Researchers, clinicians, epidemiologists
Study Period:
up to 2016
Number of Participants:
1,153,265
Study Design:
Prospective cohort studies
Main Findings:
Older age, smoking, higher adiposity, and lower alcohol consumption are associated with increased risk of venous thromboembolism
Subject:
Venous thromboembolism and P-selectin biomarker
Field:
Hematology and vascular medicine
Document type:
Scientific article abstract and overview
Topics covered:
Risk factors, pathogenesis, clinical features, complications, and diagnosis of venous thromboembolism
Biological marker discussed:
P-selectin
Medical conditions referenced:
Deep vein thrombosis (DVT), pulmonary embolism (PE), chronic thromboembolic pulmonary hypertension (CTEPH)
Diagnostic methods mentioned:
Wells score, ultrasonography, computed tomography pulmonary angiography, ventilation-perfusion scan, plethysmography, D-dimer testing, contrast venography, magnetic resonance imaging
Genetic factors referenced:
Antithrombin deficiency, protein C deficiency, protein S deficiency, factor V Leiden, prothrombin G20210A mutation
Physiological mechanisms:
Virchow’s triad, endothelial damage, venous stasis, hypercoagulability
Clinical signs referenced:
Homans sign, Louvel sign, Lowenberg sign
Figures referenced:
Flowchart of thrombosis process and diagnostic pathway for venous thromboembolism